The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1 DEEs...
Hence then, the article about lundbeck to present new data on bexicaserin at upcoming congress highlighting long term impact on seizure frequency in patients with rare epilepsy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy )
Also on site :
- '90s One-Hit Wonder That Became a Worldwide Phenomenon Began a 14-Week Run at No. 1, 30 Years Ago Today
- 1973 Hit, Written by One of the 'Best Rock Bands' of All Time, Is Still a Generational Hit 53 Years Later
- If you purchased a 48-inch or taller Bestway above-ground pool with straps running to the outside of the vertical legs since 2008, you may be entitled to benefits from a class action Settlement.